Related Experiment Video
Updated: Mar 26, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.5K
Population pharmacokinetics of plasma-derived factor IX: procedures for dose individualization
A Brekkan1, E Berntorp2, K Jensen2
1Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Journal of Thrombosis and Haemostasis : JTH
|January 26, 2016
Summary
Individualizing factor IX (FIX) dosing for hemophilia B using population pharmacokinetic (POPPK) models is feasible. Limited sampling schedules, specifically on days 2 and 3, offer convenient and effective dose adjustments for better patient outcomes.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Hemophilia B Treatment
- Drug Dosing Optimization
Background:
- Population pharmacokinetic (POPPK) models aid in individualizing factor IX (FIX) dosing for hemophilia B treatment.
- Previous POPPK models for FIX activity require reevaluation and optimization.
Purpose of the Study:
- To reevaluate a POPPK model for FIX activity.
- To determine optimal sampling schedules (number and timing) for pharmacokinetic (PK) dose individualization.
Main Methods:
- Reevaluation of a POPPK model using an expanded dataset.
- Simulation study to assess various sampling schedules and their impact on dose prediction errors.
- Comparison of individually calculated doses versus standard fixed doses based on trough FIX activity levels.
Main Results:
- A three-compartment PK model accurately describes FIX activity.
- The number and timing of FIX samples significantly affect dose prediction accuracy.
- Sampling schedules with single draws on day 2 and day 3 provide acceptable performance.
- Individually calculated doses improve patient target attainment compared to fixed dosing.
Conclusions:
- PK dose tailoring with limited sampling is potentially applicable for plasma-derived FIX products.
- Optimized sampling strategies enhance the precision of individualized FIX dosing.
- Individualized dosing strategies lead to superior therapeutic outcomes in hemophilia B patients.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
254
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
254
01:24Dosage Regimen: Individualization
279
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
355
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
355
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
322
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
322
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
429
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
429
01:28IV Infusion to Oral Dosing: Conversion Methods
131
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
131